| Nom du produit | Avanafil |
|---|---|
| Numéro CAS | 330784-47-9 |
| Formule moléculaire | C23H26ClN7O3 |
| Poids moléculaire | 483.95 g/mol |
| Apparence | Poudre cristalline blanche à blanc cassé |
| Essai (HPLC) | ≥99,01 TP3T |
| Perte au séchage | ≤0.5% |
| Résidu au feu | ≤0.1% |
| Métaux lourds | ≤ 10 ppm |
| Point de fusion | 155-160°C |
| Rotation spécifique | Not applicable (racemic) |
Besoin d'aide ? Contacter notre équipe

Avanafil, 330784-47-9, 4-[(3-Chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide.
Avanafil is a fast-acting PDE5 inhibitor that’s making waves in the erectile dysfunction market. Its quick onset of action — often within 15 minutes — sets it apart from older options, and that’s a big deal for patients who value spontaneity. For manufacturers, that translates into a competitive edge when formulating treatments that prioritize convenience and reliability.
We supply Avanafil as a high-purity powder, every batch backed by a full COA. Whether you need a small trial run or bulk quantities for production, we’re ready to ship worldwide with flexible packaging options to match your workflow.